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Abstract
Constipation remains a frequent presentation to paediatricians, with significant health resource implications. We
present a practical guide to the management of paediatric constipation and evaluate the current evidence for
treatment regimens, to help the clinician in treating a condition that can be distressing and has a significant
impact on affected families.
Introduction
Constipation is a very common presentation, both in pri-
mary and secondary care. Prevalence of functional consti-
pation in children ranges from 4-36% [1-3]. In the hospital
setting, paediatric constipation forms 3% of all referrals to
paediatric practice and up to 25% to paediatric gastroen-
terologists. In addition a recent American study suggests
that there is a cost of health resources for children with
constipation, estimated at $3.9 billion/year [4].
This article aims to be a practical guide for paediatri-
cians and primary care physicians, to outline the current
diagnostic criteria and provide an evidence-base for the
medical management of idiopathic constipation in chil-
dren, in the light of recent National Institute of Clinical
Excellence (NICE) guidelines on constipation [5]. With
increased patient and parental understanding and sup-
port, as well as improving toileting habit, increasing
fibre and optimising laxatives; the potential exists to
deliver a significant benefit to children.
Normal Bowel Habit in Children
Considerable variation in ‘normal’ bowel habit in chil-
dren is accepted. In a UK based study of 350 pre-school
children (1-4 years of age), 96% of the children passed
bowel motions between 3 times a day to alternate daily
[6]. Stool frequency is also age-dependent. Nyhan, in a
study of 800 babies described a peak frequency of 4.4
per day at 5 days of age [7], and may be as high as 13
per day in breast fed infants. Although a difference in
stool frequency may exist between breast and bottle fed
babies, time to first stool after passage of meconium
remains the same in both groups [8].
Definition
The wide variation in normal defaecation patterns in
children discussed above makes it difficult to define
constipation. Normal ranges also vary with age and
place of residence [9].
Functional constipation has been defined by the
ROME III classification [10] as 2 or more of the follow-
ing features in a child with a developmental age of at
least 4 years and occurring at least once per week for at
least 2 months before diagnosis (with insufficient criteria
for diagnosis of irritable bowel syndrome).
￿ 2 or fewer defaecations in the toilet per week
￿ At least 1 episode of faecal incontinence per week
￿ History of retentive posturing or excessive voli-
tional stool retention
￿ History of painful or hard bowel movements
￿ Presence of a large faecal mass in the rectum
￿ History of large diameter stools that may obstruct
the toilet
More recently, the term ‘non-retentive faecal soiling’
has been described for children soiling without difficult
infrequent defaecation. PACCT (The Paris Consensus
on Childhood Constipation Terminology Group) have
defined this as passage of stools in an inappropriate
place, occurring in children with a mental age of 4 years
and older, with no evidence of constipation on history
or examination [11]. The Iowa criteria of constipation in
children ≥ 2 years of age include two or more of the fol-
lowing during the previous 8 weeks:
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Large stools in the rectum or felt on abdominal
examination
Passing of stools so large that they obstruct the toilet
Retentive posturing (withholding behaviour)
Painful defecation
< 3 bowel movements per week.
How sensitive and specific are these definitions? In a
recent Turkish study on 485 children being treated for
constipation, 33 children (6.8%) were not recognised by
the Rome III criteria used in the study, due to problems
with age restriction. 45 (9.2%) children were not recog-
nized using the PACCT criteria due to only having scy-
balous, pebble-like defaection pattern (rather than
passing large stools obstructing the toilet). Only 60%
had a defaecation pattern of less than 3 per week [12].
Given below are details of individual symptoms and
their significance in relation to the definitions above.
Symptoms of constipation
1. Infrequent stools
Reduced bowel movement is commonly used to make a
diagnosis. In a study of 178 children with constipation
in Iowa, 58% had < 3 bowel movements per week [9]
and in another study 41.3% of children with symptoms
of constipation were found to have infrequent stools
[13]. Children < 2 years of age had constipation with
symptoms of passage of hard or pebble-like stools with
straining, withholding or painful defaecation. The diag-
nosis would be missed in 50% if infrequent stools were
the only criteria used for diagnosis.
2. Pain
Children may present with pain in the abdomen or dur-
ing defaecation. Non-specific abdominal pain has been
reported in 33% of children with constipation in one
study. Painful defaecation occurs when children com-
plain of pain or scream during or on anticipation of
stools, observed in up to 68% of children with constipa-
tion [9]. They may pass blood with stools (see below).
3. Soiling
Faecal incontinence has been associated with ‘constipa-
tion’ in up to 90% [13]. Soiling is involuntary, often
small and stains the underwear, however if larger in
amount can be mistaken for diarrhoea. Medications may
be incorrectly reduced which may instead need to be
maintained or increased.
4. Stool withholding manoeuvres
This may be misinterpreted as straining. In infants back-
arching, and in older infants/toddlers, standing on toes,
extending legs or rocking back and forth preventing
anal relaxation are typical features. Some children may
hide in a corner standing stiffly or squatting.
5. Blood in stools
Fissures may result in bleeding and painful defaecation
in older children. Children may present with blood on
tissue paper after wiping. Perineal examination should
include looking for infection/cellulitis, fissures, fistulae
or tags. The latter, associated with faltering growth or
delayed puberty, may be suggestive of Crohn’s disease.
Comparatively children with polyps commonly present
with painless bleeding. Rectal bleeding in infancy is
often associated with cow’s milk protein allergy rather
than constipation [14].
6. Enuresis and other urinary symptoms
Urinary symptoms have been reported in 9-13% of chil-
dren with a diagnosis of constipation, and urinary incon-
tinence 10.5%, and it has been implicated in the patho-
aetiology of enuresis [13]. Asymptomatic constipation
may exacerbate urinary symptoms in children with enur-
esis [15]. The impacted stool in the rectum compresses
the bladder, reduces its functional capacity, and provokes
earlier sensation to void. In addition, chronic pelvic floor
spasm prevents complete relaxation during voiding, and
contributes to postvoid residuals [16-18].
7. Associations
1. Obesity [19,20]
Overall a higher incidence of obesity has been found
in constipated children, compared to the general
paediatric population, with associated psychosocial
issues, poor diet, low activity levels, and compliance
problems.
2. Poor Fluid intake
Optimal fluid intake is recommended by NICE as a
necessary adjunct in the management of constipation
[5]. However, excessive fluid intake can result in
reduction in eating/fibre, which may be counter-pro-
ductive [21].
Epidemiology
A positive family history has been found in 28-50% of
constipated children and a higher incidence reported in
monozygotic than dizygotic twins [22]. Constipation
tends to be equal in both sexes below 5 years, commoner
in girls above 13 years of age, and peak incidence is at
the time of toilet training around 2-3 years of age [23].
Aetiology of idiopathic constipation
Understanding the trigger for constipation in children is
important. This may occur secondary to inadequate
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ing, quick use of the school toilet, the child withholding
stools as they may be occupied by something of greater
interest. Occasionally children may have had a hard
stool due to decreased fluid intake after a febrile illness
or during a holiday trip.
Children with difficult toilet training are more likely to
be constipated. These children may be less adaptable
and negative in mood. 74% would hide stool and 37%
would ask for pull ups to leave the stool in it [24].
These children benefit more from constant encourage-
ment using star charts/other reward techniques, rather
than confrontation (see below).
Secondary constipation, for instance due to hypothyr-
oidism, Hirschsprung’s disease, or changes in calcium
levels is rare and accounts for less than 10% of cases.
However cow’s milk protein allergy, particularly non-IgE
mediated, with associated colonic dysmotility may mani-
fest as secondary constipation [25,26], with one study
estimating its prevalence in up to 40% of refractory con-
stipation [27].
Up to 63% of children with constipation and faecal
soiling will have a history of painful defaecation begin-
ning before 3 years of age and secondary withholding
behaviour [28,29]. Stool with-holding follows passing a
hard painful bowel motion, creating a vicious cycle of
pain leading to further withholding, stool hardening and
increase in size with subsequent megarectum, lack of
defaecatory signal etc. Parents may mistake such with-
holding behaviour as straining.
Diagnosis
Constipation is diagnosed by clinical history and exami-
nation. History should include a detailed exploration of
symptoms, looking at potential precipitants, and for ‘red
flags’ to exclude organic pathology (see table 1). A phy-
sical examination should include an abdominal examina-
tion to assess the degree of faecal loading, as well as
neurological assessment of the spine and lower limbs.
Perineal examination helps to look for perianal cellulitis
and anorectal anomalies. There is now clear NICE gui-
dance on rectal examinations in children that these
should only be performed by healthcare professionals
who are competent in recognising anorectal anatomical
problems and Hirschsprung’s disease, and this examina-
tion can provide useful information on sphincter tone,
and rectal loading. Constipation should be considered as
a differential diagnosis in all children presenting with
abdominal pain [30]. In a child with an underlying neu-
rological diagnosis or developmental delay, irritability
may be suggestive; and a high index of suspicion main-
tained, as constipation may be present in the context of
gut dysmotility. Constipation may be missed in 1/3
rd of
children with autism if clinical criteria alone are used to
make a diagnosis [31]. Other considerations include an
association between children with refractory constipa-
tion and abuse but features such as soiling should be
placed into context and are not discriminatory in isola-
tion [32].
It is important to watch for growth failure, ‘overflow
diarrhoea’ with blood and/or mucus, pallor or fatigue, or
failure to respond to conventional treatment during the
course of management, and be prepared to re-evaluate.
Children with inflammatory bowel conditions (with or
without anal involvement) and coeliac disease may pre-
sent with constipation. It is important to remember that
like fever, constipation may be a symptom and not a
diagnosis.
Finally, even in idiopathic constipation, it is useful to
understand the underlying mechanics and family
dynamics, which, if not addressed, may often lead to
failure of intensive laxative treatment.
Investigations
Often tests are not needed and only conducted to
exclude secondary constipation. A nutritional assess-
ment may be part of the initial blood screen which
includes screening for thyroid and coeliac disease [5]. In
children with constipation specific IgE to cow’sm i l ki s
not diagnostic of cow’s milk allergy [25;26].
Plain abdominal X ray
Constipation is a clinical and not a radiological diagno-
sis. Occasionally a plain abdominal × ray is useful in
cases of diagnostic uncertainty, but remains highly sub-
jective. Scoring systems have been trialled to improve
consistency. One system, the Leech system [33] divides
the abdominal × ray into three sections, ascending colon
and proximal transverse colon; distal transverse colon;
descending colon and rectosigmoid area. Each segment
is then assessed for the presence of stools (score 0-5
where 0 indicates no stool; 5 means gross faecal loading
with bowel dilation). The Leech system has been shown
Table 1 Red Flags: Common symptoms and signs to
suggest organic causes of constipation
History Examination
Failure to thrive Absent/Brisk lower limb
reflexes
Delayed passage of meconium Mouth ulcers
Abnormal bowel habit since birth Blood/mucus mixed in
with stool
Sensitivity to cold, fatigue, dry skin,
pallor
Perianal skin tags or
fistulae
Change of bowels with introduction of
cow’s milk
Associated hypotonia
Weight loss Fever
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by two paediatric radiologists for validity (kappa values
of 0.88 and 1.00, P < 0.05) [34]. In another study X-rays
were comparatively scored by a student, junior doctor
and consultant. The results suggested that scoring by
these systems is dependent on the experience of the
observer, and does not accurately discriminate between
constipated children and children without constipation
[35].
Presence of firm, packed hard stool in the rectum cor-
relates closely with radiological evidence of faecal reten-
tion, with sensitivity and positive predictive values
exceeding 90% [33,36,37].
A ‘Shapes’ bowel transit study, where a patient ingests
three different radio-opaque marker shapes on consecu-
tive days and a subsequent × ray on day 4 identifies
where these markers are, can be very helpful in deter-
mining specific anatomical area of hold up. For instance
recto-sigmoid accretion of markers would be observed
in long-standing constipation of idiopathic origin, such
as with stool withholding, whereas markers may be dis-
tributed more widely throughout a dysmotile colon.
Ultrasound
Bijoś has described using ultrasound (USS) for diagnosis
of constipation [38]. The transverse diameter of the rec-
tal ampulla increases with age and thus influenced the
USS measurements in both the patient and control
groups. The numerical values of this parameter differed
significantly between patients and controls in all age
groups. The rectopelvic ratio is the ratio of the width of
the rectal ampulla (on USS) to the distance between the
anterior superior iliac spines (measured externally using
a measuring tape) and has been used to define
‘megarectum’.
Anorectal/Colonic Manometry
This is not a first line investigation but has been used in
children with refractory symptoms, often with failed
multiple treatments, who may have had required multi-
ple hospitalisations for treatment of their symptoms.
Presence and normal propagation of high amplitude
propagating contractions (HAPCs) with presence of a
gastro-colonic response is suggestive of intact neuro-
muscular function. The highest prevalence of motor
abnormalities have been reported in children with
intestinal pseudo-obstruction [39]. Colonic manometry
can be useful for planning surgical intervention in chil-
dren with refractory symptoms.
Rectal biopsy
Deep suction rectal biopsy is the gold standard for diag-
nosing Hirschsprung’s disease. If the age at onset of
constipation is after the neonatal period, Hirschsprung’s
disease is very unlikely [40]. Ultra short Hirschsprung’s
disease is rare, and was first described by Davidson and
Bauer in 1958 [41]. Strip biopsies are recommended to
avoid falsely negative biopsies. Strip biopsies include
mucosa from the dentate line to the rectum, and a full
thickness biopsy is preferable.
Management
The practicing physician should be up to date with the
principles of management. Recently published data from
Virginia (USA) suggested that up to 86% of the primary
care physicians had no awareness of the published clini-
cal guidelines for constipati o ni nc h i l d r e n[ 4 2 ] .A f t e r2
months of treatment, nearly 40% of children remained
symptomatic; which was improved by improved parental
understanding and regular laxatives [43].
Education
Parental/family education regarding their understanding
of the aetiology, symptoms and principles of manage-
ment remain critical in achieving success. Management
starts with explaining the physiological basis of constipa-
tion and soiling to the child and family. NICE recom-
mend that the child should never be blamed for soiling
and this should be explained to parents [5].
T h ef a m i l ys h o u l db ee n c o u r a g e dt oa d h e r et ot h e
treatment plan (both medication and a regular toileting
pattern) with emphasis on its efficacy for long-term
symptom improvement. Underlying psychosocial pro-
b l e m ss h o u l db ec o n s i d e r e di nt h ef i r s tm e e t i n g .T h e s e
may range from bullying to pressure to use a single
family toilet quickly. Clear and simple messages should
be given to avoid overwhelming the family.
Toileting at school may need to be addressed with the
teacher with involvement of the school nurse. Boyt [44]
in a postal questionnaire in Iowa, described lack of
awareness of most teachers regarding childhood consti-
pation. One third of respondents indicated that they ask
children to wait to go to the bathroom. Suboptimal con-
ditions existed in most school toilets, with only 35% of
the boys’ toilets and 48% of the girls’ toilets reported as
“always clean”.
Diet
NICE recommend optimising fibre intake [5,45-47].
Children with normal defaecation patterns in compari-
son to children with constipation have better fibre
intake. A strong family history of cow’s milk protein
intolerance, or raised eosinophil count, and elevated
specific IgE to cow’s milk, would merit a trial of cow’s
milk protein-free diet, and in infants, a hydrolysed for-
mula [26]. A trial of cow’s milk protein-free diet is also
merited for non-IgE-mediated cow’s milk protein intol-
erance, in those with a suggestive history, for example if
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mula-feeding [48], or in those with refractory constipa-
tion [25]. Increased fluid intake is recommended [5;49],
but not at the expense of excessively restricting calorie
intake in younger children.
Evidence base for medications used in treatment
of constipation in children
Search criteria
We searched PubMed, Medline, and Embase and then
hand search reviews from the past 5 years for ‘constipa-
tion’, ‘soiling’, ‘faecal’, ‘fecal’, ‘incontinence’, ‘child$’,
‘infant’, ‘baby’, ‘drugs’, ‘therapy’ and ‘treatment’.R e v i e w s
and abstracts are excluded. We appraised the original
clinical trials using the Levels of Evidence adopted by
the Oxford Centre for Evidence-based Medicine, and
produced evidence-based recommendations [50]. We
have constructed a flow chart, showing the outcome of
t h es e a r c h ,t h en u m b e ro fe x c l u d e dp a p e r sb yr e a s o n
f o re x c l u s i o na n dn u m b e ro fp apers selected for review
(Figure 1).
Disimpaction
Disimpaction is important, particularly in severe cases,
for maintenance treatment to work, according to NICE
[5]. An escalating dose of polyethylene Glycol (PEG) is
recommended as first-line treatment (see evidence
below) with a stimulant added if required. The family
should be prepared for potential worsening of overflow
soiling initially. An excessive dose of stimulant risks pre-
cipitating acute abdominal pain in cases of impaction. If
possible, such treatments should commence during
weekends/holidays to minimise stress for the child and
family. Diarrhoea in a constipated child initialising a
treatment is likely to represent spurious overflow diar-
rhoea and the treatment would need to be increased or
at least maintained rather than reduced. It is sensible to
review the child regularly. In practical terms, this may
mean 2-3 appointments 1-2 weeks apart initially. Specia-
list nurses can play a major role during this period. Dis-
impaction should generally be initiated orally; further
discussion of enemas is outlined below.
Maintenance therapy
Once disimpaction has taken place, the aim of laxative
treatment, as recommended by NICE, should be to keep
the child, symptom free with regular soft bowel actions
and should be commenced immediately [5], initially at
half the dose required for disimpaction. PEG is the first
line treatment, with a stimulant laxative such as senna
added if required, or substituted if PEG is not tolerated.
During this period, the child should be encouraged to
use the toilet regularly, particularly 15-30 minutes after
meals. A useful rule of thumb is to aim for 1-2 soft
stools a day, though this is not definitive. Laxative treat-
ment needs to be tailored to the child; and toilet train-
ing can often be as important as the choice of laxatives.
Give parents the support to allow them to vary the laxa-
tive dose in response to their child’ss y m p t o m s( f o r
example through telephone advice from a specialist
nurse). Once improvement is seen, laxatives should be
gradually reduced and never stopped suddenly. Improve-
ment in chronic cases may take place over months and
can take years in some cases. Reinforcement of the man-
agement plan may be required. Relapses are common
and may need to be treated with increasing doses of
laxatives. A reward system with star chart is often used
with success. Finally, toilet training should be postponed
in a constipated 2-year old until after disimpaction.
Choice of laxatives may vary between regions and
countries. Lactulose, macrogols, and Senna (table 2, 3,
4) are popularly used treatments in the UK. In the sec-
t i o nb e l o ww eh a v el o o k e da tt h ea v a i l a b l ee v i d e n c eo f
efficacy of these medications, with an abbreviated dis-
cussion of mineral oil, erythromycin and magnesium
hydroxide (due to the paucity of evidence). The evidence
base for enemas (table 5) is also reviewed.
Lactulose (see table 2) [51-56]
Summary
Older case series of variable quality point to some bene-
fit. However RCTs have shown either inferiority to PEG
(Voskuijl et al, Dupont et al) or absence of benefit (von
Ginkel, Gremse et al).
Conclusions
Evidence points to a lack of benefit from lactulose, but
more studies are needed (Grade B).
Inclusions:33Originalclinicaltrials(includingheadtohead)
Lactuloseevaluatedin7.
Senna:4papers
PEG:18papers
MagnesiumHydroxide:2papers*
Erythromycin:1paper*
MineralOil:3papers*
Enema:3papers
Reviews:Lessthan5y:9reviews
Olderthan5y:10reviews.
*Forbrevityreviewofthesedrugshasbeentruncated.
Exclusions:
Alternativetherapies:4
FollowǦupstudies:not
treatment:5
NotEnglishlanguage:3
Focusnotfunctional
constipation:5.
Notpaediatric:2
Abstractonly:7(notlisted
below)
Resultsofsearch=982abstracts
78articles
identified
904notrelevant
26Articlesdiscounted
33clinicaltrials 19reviews
52articlesselected
Figure 1 Flow Chart
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Summary
Certainly PEG is now recommended as first line treat-
ment as per UK NICE guidelines [5]. The studies cover
the different scenarios of treatment: oral resolution of
impaction and maintenance therapy for relief of consti-
pation. Both PEG +E and PEG 3350 were evaluated.
The largest studies (Thomson et al, Candy et al, Dupont
et al, Youssef et al) demonstrate efficacy in resolution of
symptoms from chronic constipation. Candy et al (2
nd
phase of study) found that PEG gave greater stool fre-
quency and had less adverse effects than lactulose.
Michail et al evaluated the dose range for children < 18
m and found that a safe and effective dose was 0.78 g/
kg/day. Loening-Baucke et al and Pashankar et al found
a similar dose was safe and effective for older children
over a mean period of over 8 months.
Conclusions
PEG is safe and effective in the treatment of impaction
and chronic constipation. (grade B)
Senna: (see table 4) [53,56,71,72]
Summary
4 low-quality studies provide little evidence of benefit
from Senna. Sondheimer et al found that mineral oil
(compared to senna) was more likely to reduce the fre-
quency of soiling and recurrence of symptoms of consti-
pation. Perkin found that lactulose was significantly
more likely to give greater number of days of normal
stool motions compared to senna. Berg compared senna
to placebo and found no significant differences in the
number of soiling episodes per week. UK NICE gui-
dance recommends stimulant use second line to PEG
solutions [5].
Conclusions
Based on current evidence there is no benefit seen from
senna, although no high-quality trials exist to date.
(Grade D)
Enemas: (see table 5) [9,43,56]
Summary
Enemas in these case series were used to relieve impac-
tion prior to initiation of maintenance therapy. The
authors would recommend a RCT comparing enema vs.
no enema relief of faecal impaction to further assess the
impact enemas have, both in the acute management and
in the medium to long-term.
Conclusion
More evidence is needed to assess the role of enemas in
impaction. (Grade D).
Erythromycin
1 study of 14 children showed some significant results:
Further evaluation through RCTs is needed to assess
erythromycin as an adjunct in chronic constipation [73].
Magnesium hydroxide
1 paper showed magnesium hydroxide inferior to PEG
[60]. More evidence is needed to evaluate the role of
magnesium hydroxide in constipation (grade D)
Mineral Oil
3 papers were identified. Gleghorn et al [74] showed
that mineral oil was effective in treating impaction in
children, and Tolia [75] showed that whilst mineral oil
Table 2 Lactulose
Authors Study Group+
type
Methods + Key Outcomes
Voskuijl et al (2004)
[51]
100 patients
Study type :1b
Methods: 8 wk double blinded, multi-centre RCT: PEG 3350 vs lactulose.
Results: Success greater for PEG group (56%) vs. lactulose group (29%) (less pain/straining). PEG significantly
less palatable
Van Ginkel (2000) [52] 48 children
Study type :2b
Methods: RCT: Biofeedback+ lactulose vs. biofeedback for 7 weeksResults: Both groups had improved
encopresis (group 2 significantly better (86%) than group 1 (53%) p < 0.01).
Gremse et al (2002)
[59]
44 children
Study type :1b
Methods: Unblinded Crossover RCT Lactulose vs PEG 3350: 2 weeks
Results: Lactulose had a significantly longer mean transit time compared to PEG 3350 (55.3 vs. 47.6 hrs,
p = 0.038). Stool form, frequency, and ease of passage were similar for each laxative.
Perkin (1977) [53] 21 children
Study type :2b
Methods: Randomised unblinded crossover study lactulose vs senna:3 weeks Results: Lactulose more likely
to give greater number of days when normal stools were passed (p < 0.01). Side-effects significantly higher
(p < 0.001) for senna.
Dupont et al (2005)
[54]
96 children
Study type :2b
Method: Random allocation, open label cohort study
Results: More than 90% of children recovered normal bowel habits. Faecal mass in the rectum and
abdominal pain were markedly reduced and appetite improved.
Keuzen-kamp et al
(1996) [55]
244 patients
Study type :4
Methods: Case series over 25y: median follow up of 4 years
3 phases: 1) evacuation with lactulose/bisacodyl
2)maintenance: regular toileting + wean laxatives to ensure soft stools daily
3) introduce high fibre diet +wean laxatives.
Results: 66% cured, 34% still symptomatic, 12 had persistent symptoms. Of all 39% had at least one
recurrence.
Connolly et al (1974)
[56]
164 patients
Study type :4
Methods: Open-label cross-over study: lactulose vs. irritant laxatives: (Senna/bisacodyl) 7 days
Results: 58% of lactulose group vs 42% of stimulant group had normal stool.
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PEG 4000
Authors Study Group
Study type
Methods+Key Outcomes
Thomson et al (2007)
[57]
51 children
Study type : 1b
Methods: Double-blind crossover RCT PEG+E or placebo for 2 weeks
Results: Mean number of defaecations higher for PEG+E group vs placebo (p < 0.001). Also PEG+E
reduced pain on defaecation (p = 0.041), straining on defaecation (p < 0.001), stool consistency (p <
0.001) and percentage of hard stools (p = 0.001). Adverse events were all mild or moderate and were
similar for those children on PEG+E and placebo.
Candy et al (2006) [58] 63 children
Study type : 2b
Methods: Initial open cohort study of PEG+E (disimpaction) then double-blind RCT of PEG+E (Movicol)
vs. lactulose (maintenance)
Results: Disimpaction) successful in 92% children. Maximum dose = 4 sachets -4 yr old) or 6 sachets
(5-11 yr olds); median time to disimpaction was 6 days.
Maintenance: Greater mean stool frequency in PEG + E group (p = 0.007).
Dupont et al (2005) [54] - Study described in the ‘Lactulose section’ - table
PEG 3350
Gremse et al (2002) [59] Study described in the ‘Lactulose section’ - table
Loening-Baucke et al
(2006) [60]
79 children
Study type : 2b
Methods: Double blind RCT PEG 3350 vs. magnesium hydroxide
Results: Significant improvement in both groups, (frequency of bowel movements, reduced frequency of
incontinence, and resolution of abdominal pain). Compliance = 95% (PEG) vs. 65% = milk of magnesia.
At 12 months, 62% of PEG-treated children and 43% of MoM-treated children improving:.
Youssef et al (2002)
[61]
40 children
Study type : 1b
Methods: Prospective double-blind, parallel RCT 4 doses of PEG 3350
Results: Disimpaction in 75% of children overall but significant difference between two higher doses vs.
lower doses (95% vs. 55%, P < .005). All groups had an increased number of bowel movements during
the 5-day study versus baseline.
Michail et al
(2004) [62]
28 patients Method: Cohort study with PEG. Mean duration 6 months
Results: Mean effective maintenance dose was 0.78 g/kg/day. PEG relieved constipation in 97.6% of
patients.
Voskuijl et al (2004) [51] Study described in the ‘Lactulose section’ - table
Ingebo (1988) [63] 24 patients
Study type : 4
Methods: Case series: PEG+E given at 14-40ml/kg/hr until clear fluid obtained.
Results: children with encopresis required an average of 11L over 22 h. PEG+E successful in all children,
and was safe.
Miller et al (2007) [64] 121 patients
Study type : 4
Methods: Case series: single-site: All children over 6 month period diagnosed with ‘constipation’ from an
Emergency Department.
Results: 2/3 had had pain for less than 1 week. 70% received an AXR. 1/3 received an enema in the ED.
74% received laxatives on discharge (80% given PEG). At follow-up, 35% were using laxatives, and 27%
had sought additional care.
After an enema, 28% discharged without laxatives.
Pashankar et al (2003)
[66]
83 children
Study type : 2b
Methods: Cohort study for at least 3 m PEG given at 0.8 g/kg/day then adjusted to give 2 soft painless
stools/day
Results: Mean duration = 8.7 months. Mean PEG dose was 0.75 g/kg daily. No major adverse effects. All
children preferred PEG to other laxatives, Good daily compliance in 90% of children
Pashankar et al (2003)
[65]
74 children
Study type :4
Methods: Case series: All given PEG 3350 for > 3 months.
Results: mean duration of PEG therapy = 8.4 m (3-30 m). Weekly stool frequency, stool consistency, and
soiling improved significantly with PEG therapy in all patients.
Pashankar et al (2001)
[67]
24 children
Study type : 4
Cohort study: PEG for 8 weeks starting at 1 g/kg/d: adjusted every 3 days aiming: 2 soft stools/d.
Results: Weekly stool frequency increased from 2.3 to 16.9 (p < .0001) with treatment. Stool consistency
improved (p < .0001). Mean effective dose was 0.84 g/kg/d (range, 0.27-1.42 g/kg/d)
Erickson (2003) [68] 46 patients
Study type : 4
Method: Retrospective review of PEG 3350, aiming for 2 soft stools a day.
Results: PEG caused significant increase in frequency of bowel movements (p = 0.0001). Average final
dose was 0.63 gm/kg. Diarrhoea in 9 patients. 18 became dry, 26 had decreased wetting (2 no
improvement).
Hanson (2006) [69] 23 children
Study type : 4
Method: Case series: 7 day disimpaction then maintenance PEG.
Results: 23 questioned on their children’s experiences. 96% ‘more than happy’ with PEG+E. Prior to PEG
+E treatment, 57 per cent of children were admitted to hospital and 26 per cent required home visits
for constipation treatment. After treatment, no child visited hospital/needed home visit.
Loening-Baucke et al
(2004) [70]
75 constipated
children
< 2 years
Study type : 4
Method: Retrospective case series: PEG.
Results: Mean effective short-term PEG dose was 1.1 g/kg/day and the mean long-term dose was
0.8 g/kg/day. Constipation was relieved in 85% with short-term and in 91% with long-term PEG therapy.
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Sondheimer in a non-blinded study showed mineral oil
to be superior to Senna in reducing constipation recur-
rences when used over 3 months [72]. More evidence is
needed to assess the role of mineral oil in treating con-
stipation (Grade D).
Management of difficult/refractory constipation
Initial history and examination should be undertaken at
the first appointment to exclude an organic aetiology
and active investigations (as mentioned before) should
be undertaken. If these reveal evidence of slow colonic
transit, this may suggest a neuronal disorder of the
intestine, which may require colonic manometry and a
full thickness biopsy for definitive diagnosis.
As discussed earlier, continued extraneous factors
such as bullying, adverse family dynamics and child
abuse should be considered. Equally, children with neu-
rological/psychiatric conditions may find it difficult to
learn/adhere to a toileting routine. Negotiated and non-
punitive behavioural interventions in conjunction with
medicinal and dietary treatment is recommended by
NICE guidance [5]. A period of inpatient admission may
be useful. This can be aided by a multi-disciplinary
team, including nurses experienced in managing chil-
dren with constipation. Psychologists and play therapists
can introduce methods of relaxation for toileting and
dieticians can also input into fluid intake and fibre
content.
S u r g e r ys h o u l do n l yb ec o n s i d e r e df o ra p p r o p r i a t e
organic indications or if medical management at a ter-
tiary level fails, and is beyond the scope of this article.
Prognosis
A high proportion of relapses have been reported after
success in the initial treatment. These relapses have
been reported to be commoner in boys than girls [76].
However the prognosis for constipation in under fives is
excellent, with constipation resolving in 88% of children
in this age group, when followed over an eighteen-
month period. The non-responders came from families
with increased degree of psychosocial problems where
reduced compliance of medications was suspected [77].
In general 50% of children with chronic constipation
will be cured after a year and 65-70% after 2 years, with
much higher rates in motivated, adherent families [78].
Two studies show 34-37% to be still constipated 3-12
years after start of treatment [9,55].
Conclusion
In this article we have outlined the current trends in the
assessment and treatment of constipation and reviewed
the current evidence-base for the therapies currently in
wide use, within the context of recent NICE guidance.
Constipation remains a prevalent problem, which can
have a huge impact on children’sq u a l i t yo fl i f e ,a n d
places a burden on primary and secondary care. With
increased patient and parental understanding and
Table 4 Senna
Authors Study Group+ type Methods+ Key Outcomes
Berg (1983) [71] 44 children with soiling
(mean age 7.9 years)
Study type 2b
All given toileting advice.
RCT: senna vs. placebo vs. no treatment.
Results: All groups improved from baseline (p < 0.05). Senna no more effective than placebo/no
treatment.
Perkin (1977) [53]- Study described in the ‘Lactulose section’ - table
Sondheimer et al
(1982) [72]
37 children
Study type: 2b
Methods: Non-blinded RCT Senna vs. mineral oil for 3 months
Results: Faecal soiling + decreased stool frequency) significantly better in mineral-oil group. At
least 1 recurrence of symptoms occurred in 66% of mineral-oil-treated and 89% of Senna-treated
patients.
Connolly et al (1974) [56] -Study described in the ‘Lactulose section’ - table.
Table 5 Enemas
Authors Study Group
Study type
Methods+ Key Outcomes
Loening-Baucke (1993) [9] 174 children
Study type: 4
Methods: case series: Long-term follow-up questionnaire. All given education, enemas for
disimpaction, and dietary fibre+ magnesium hydroxide.
Results: On presentation 64% impacted +received enema. 57/90 (63%) had recovered. 17 (19%) still
required laxatives, and 16 (18%) still soiling regularly.
Borowitz et al (2005) [43] 119 children
Study type: 4
Methods: Case series: Follow-up: Colonic evacuation then magnesium hydroxide (77%), senna syrup
(23%), mineral oil (8%), and lactulose (8%)
Results: Children who underwent some form of colonic evacuation followed by daily laxative therapy
were more likely to have responded to treatment (p < 0.05).
Miller et al (2007) [64] See PEG section above
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Page 8 of 10support, as well as improving toileting habit, increasing
fibre and optimising laxatives; the potential exists to
deliver a significant benefit to children, and revolutio-
nise what can otherwise be an intractable and distres-
sing condition.
Author details
1Paediatric Department, Southampton University Hospitals NHS Trust,
Southampton General Hospital, Tremona Rd, Southampton, Hants, SO16
6YD, England.
2Paediatric Department, Poole Hospital NHS Trust, Longfleet
Rd, Poole, BH15 2JB, England.
3Department of Paediatric Gastroenterology,
The Sheffield Children’s NHS Trust, Western Bank, Sheffield, S10 2TH,
England.
Authors’ contributions
MAT and NAA conceived the article. MPT performed and wrote the
literature search, and NAA wrote the article. MPT and NAA edited the article
for publication. All authors have read and approved the script
Competing interests
The authors declare that they have no competing interests.
Received: 30 December 2010 Accepted: 13 June 2011
Published: 13 June 2011
References
1. van der Wal MF, Benninga MA, Hirasing RA: The prevalence of encopresis
in a multicultural population. J Pediatr Gastroenterol Nutr 2005, 40:345-348.
2. de Araujo Sant’Anna AM, Calcado AC: Constipation in school-aged
children at public schools in Rio de Janeiro, Brazil. J Pediatr Gastroenterol
Nutr 1999, 29:190-193.
3. Yong D, Beattie RM: Normal bowel habit and prevalence of constipation
in primary-school children. Ambulatory Child Health 1998, 4:277-282.
4. Liem O, Harman J, Benninga M, Kelleher K, Mousa H, Di LC: Health
utilization and cost impact of childhood constipation in the United
States. J Pediatr 2009, 154:258-262.
5. NICE Guidelines: Constipation in children. Internet Communication 2010
[http://www.nice.org.uk/guidance/CG99].
6. Weaver LT, Steiner H: The bowel habit of young children. Arch Dis Child
1984, 59:649-652.
7. Nyhan WL: Stool frequency of normal infants in the first week of life.
Pediatrics 1952, 10:414-425.
8. Metaj M, Laroia N, Lawrence RA, Ryan RM: Comparison of breast- and
formula-fed normal newborns in time to first stool and urine. J Perinatol
2003, 23:624-628.
9. Loening-Baucke V: Constipation in early childhood: patient
characteristics, treatment, and longterm follow up. Gut 1993,
34:1400-1404.
10. Rasquin A, Di LC, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS:
Childhood functional gastrointestinal disorders: child/adolescent.
Gastroenterology 2006, 130:1527-1537.
11. Benninga M, Candy DC, Catto-Smith AG, Clayden G, Loening-Baucke V,
Di LC, Nurko S, Staiano A: The Paris Consensus on Childhood
Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr
2005, 40:273-275.
12. Aydoðdu S, Çakýr M, Yüksekkaya HA, Arýkan C, Tümgör G, Baran M,
Yaðcý RV: The Turkish Journal of Pediatrics 2009, 51:146-153.
13. Loening-Baucke V: Prevalence rates for constipation and faecal and
urinary incontinence. Arch Dis Child 2007, 92:486-489.
14. Arvola T, Ruuska T, Keranen J, Hyoty H, Salminen S, Isolauri E: Rectal
bleeding in infancy: clinical, allergological, and microbiological
examination. Pediatrics 2006, 117:e760-e768.
15. O’Regan S, Yazbeck S, Hamberger B, Schick E: Constipation a commonly
unrecognized cause of enuresis. Am J Dis Child 1986, 140:260-261.
16. Farhat W, Bagli DJ, Capolicchio G, O’Reilly S, Merguerian PA, Khoury A,
McLorie GA: The dysfunctional voiding scoring system: quantitative
standardization of dysfunctional voiding symptoms in children. J Urol
2000, 164:1011-1015.
17. Koff SA, Wagner TT, Jayanthi VR: The relationship among dysfunctional
elimination syndromes, primary vesicoureteral reflux and urinary tract
infections in children. J Urol 1998, 160:1019-1022.
18. Yazbeck S, Schick E, O’Regan S: Relevance of constipation to enuresis,
urinary tract infection and reflux. A review. Eur Urol 1987, 13:318-321.
19. Misra S, Lee A, Gensel K: Chronic constipation in overweight children.
JPEN J Parenter Enteral Nutr 2006, 30:81-84.
20. Pashankar DS, Loening-Baucke V: Increased prevalence of obesity in
children with functional constipation evaluated in an academic medical
center. Pediatrics 2005, 116:e377-e380.
21. Issenman RM, Hewson S, Pirhonen D, Taylor W, Tirosh A: Are chronic
digestive complaints the result of abnormal dietary patterns? Diet and
digestive complaints in children at 22 and 40 months of age. Am J Dis
Child 1987, 141:679-682.
22. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G: Evidence of a
genetic contribution to functional bowel disorder. Am J Gastroenterol
1998, 93:1311-1317.
23. Di LC: Pediatric anorectal disorders. Gastroenterol Clin North Am 2001,
30:269-87, ix.
24. Schonwald A, Sherritt L, Stadtler A, Bridgemohan C: Factors associated
with difficult toilet training. Pediatrics 2004, 113:1753-1757.
25. Irastorza I, Ibanez B, Delgado-Sanzonetti L, Maruri N, Vitoria JC: Cow’s-milk-
free diet as a therapeutic option in childhood chronic constipation. J
Pediatr Gastroenterol Nutr 2010, 51:171-176.
26. El-Hodhod MA, Younis NT, Zaitoun YA, Daoud SD: Cow’s milk allergy
related pediatric constipation: appropriate time of milk tolerance. Pediatr
Allergy Immunol 2010, 21:e407-e412.
27. Iacono G, Cavataio F, Montalto G, Florena A, Tumminello M, Soresi M,
Notarbartolo A, Carroccio A: Intolerance of cow’s milk and chronic
constipation in children. N Engl J Med 1998, 339:1100-1104.
28. Partin JC, Hamill SK, Fischel JE, Partin JS: Painful defecation and fecal
soiling in children. Pediatrics 1992, 89:1007-1009.
29. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ,
Staiano A: Childhood functional gastrointestinal disorders. Gut 1999, , 45
Suppl 2: II60-II68.
30. Loening-Baucke V, Swidsinski A: Constipation as cause of acute abdominal
pain in children. J Pediatr 2007, 151:666-669.
31. Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R:
Constipation with acquired megarectum in children with autism.
Pediatrics 2003, 112:939-942.
32. Mellon MW, Whiteside SP, Friedrich WN: The relevance of fecal soiling as
an indicator of child sexual abuse: a preliminary analysis. J Dev Behav
Pediatr 2006, 27:25-32.
33. Leech SC, McHugh K, Sullivan PB: Evaluation of a method of assessing
faecal loading on plain abdominal radiographs in children. Pediatr Radiol
1999, 29:255-258.
34. van den BM, Graafmans D, Nievelstein R, Beek E: Systematic assessment of
constipation on plain abdominal radiographs in children. Pediatr Radiol
2006, 36:224-226.
35. Jackson CR, Lee RE, Wylie AB, Adams C, Jaffray B: Diagnostic accuracy of
the Barr and Blethyn radiological scoring systems for childhood
constipation assessed using colonic transit time as the gold standard.
Pediatr Radiol 2009.
36. Rockney RM, McQuade WH, Days AL: The plain abdominal
roentgenogram in the management of encopresis. Arch Pediatr Adolesc
Med 1995, 149:623-627.
37. van den BM, Graafmans D, Nievelstein R, Beek E: Systematic assessment of
constipation on plain abdominal radiographs in children. Pediatr Radiol
2006, 36:224-226.
38. Bijos A, Czerwionka-Szaflarska M, Mazur A, Romanczuk W: The usefulness of
ultrasound examination of the bowel as a method of assessment of
functional chronic constipation in children. Pediatr Radiol 2007,
37:1247-1252.
39. Pensabene L, Youssef NN, Griffiths JM, Di LC: Colonic manometry in
children with defecatory disorders. role in diagnosis and management.
Am J Gastroenterol 2003, 98:1052-1057.
40. Ghosh A, Griffiths DM: Rectal biopsy in the investigation of constipation.
Arch Dis Child 1998, 79:266-268.
41. Davidson M, Bauer CH: Studies of distal colonic motility in children. IV.
Achalasia of the distal rectal segment despite presence of ganglia in the
myenteric plexuses of this area. Pediatrics 1958, 21:746-761.
Afzal et al. Italian Journal of Pediatrics 2011, 37:28
http://www.ijponline.net/content/37/1/28
Page 9 of 1042. Whitlock-Morales A, McKeand C, DiFilippo M, Elitsur Y: Diagnosis and
treatment of constipation in children: a survey of primary care
physicians in West Virginia. W V Med J 2007, 103:14-16.
43. Borowitz SM, Cox DJ, Kovatchev B, Ritterband LM, Sheen J, Sutphen J:
Treatment of childhood constipation by primary care physicians: efficacy
and predictors of outcome. Pediatrics 2005, 115:873-877.
44. Boyt MA: Teachers’ knowledge of normal and abnormal elimination
patterns in elementary school children. J Sch Nurs 2005, 21:346-349.
45. Hillemeier C: An overview of the effects of dietary fiber on
gastrointestinal transit. Pediatrics 1995, 96:997-999.
46. Morais MB, Vitolo MR, Aguirre AN, Fagundes-Neto U: Measurement of low
dietary fiber intake as a risk factor for chronic constipation in children. J
Pediatr Gastroenterol Nutr 1999, 29:132-135.
47. Guimaraes EV, Goulart EM, Penna FJ: Dietary fiber intake, stool frequency
and colonic transit time in chronic functional constipation in children.
Braz J Med Biol Res 2001, 34:1147-1153.
48. du TG, Meyer R, Shah N, Heine RG, Thomson MA, Lack G, Fox AT:
Identifying and managing cow’s milk protein allergy. Arch Dis Child Educ
Pract Ed 2010, 95:134-144.
49. Jennings A, Davies GJ, Costarelli V, Dettmar PW: Dietary fibre, fluids and
physical activity in relation to constipation symptoms in pre-adolescent
children. J Child Health Care 2009, 13:116-127.
50. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M:
Levels of Evidence: Oxford Centre for Evidence-based Medicine. Centre
for Evidence Based Medicine, Department of Primary Care, Old Road Centre,
Oxford 2009.
51. Voskuijl W, de LF, Verwijs W, Hogeman P, Heijmans J, Makel W, Taminiau J,
Benninga M: PEG 3350 (Transipeg) versus lactulose in the treatment of
childhood functional constipation: a double blind, randomised,
controlled, multicentre trial. Gut 2004, 53:1590-1594.
52. van GR, Benninga MA, Blommaart PJ, van der Plas RN, Boeckxstaens GE,
Buller HA, Taminiau JA: Lack of benefit of laxatives as adjunctive therapy
for functional nonretentive fecal soiling in children. J Pediatr 2000,
137:808-813.
53. Perkin JM: Constipation in childhood: a controlled comparison between
lactulose and standardized senna. Curr Med Res Opin 1977, 4:540-543.
54. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A,
Baranes C, Benoit S, Benssoussan A, Boussioux JL, Boyer P, Brunet E,
Delorme J, Francois-Cecchin S, Gottrand F, Grassart M, Hadji S, Kalidjian A,
Languepin J, Leissler C, Lejay D, Livon D, Lopez JP, Mougenot JF, Risse JC,
Rizk C, Roumaneix D, Schirrer J, Thoron B, Kalach N: Double-blind
randomized evaluation of clinical and biological tolerance of
polyethylene glycol 4000 versus lactulose in constipated children. J
Pediatr Gastroenterol Nutr 2005, 41:625-633.
55. Keuzenkamp-Jansen CW, Fijnvandraat CJ, Kneepkens CM, Douwes AC:
Diagnostic dilemmas and results of treatment for chronic constipation.
Arch Dis Child 1996, 75:36-41.
56. Connolly P, Hughes IW, Ryan G: Comparison of “Duphalac” and “irritant”
laxatives during and after treatment of chronic constipation: a
preliminary study. Curr Med Res Opin 1974, 2:620-625.
57. Thomson MA, Jenkins HR, Bisset WM, Heuschkel R, Kalra DS, Green MR,
Wilson DC, Geraint M: Polyethylene glycol 3350 plus electrolytes for
chronic constipation in children: a double blind, placebo controlled,
crossover study. Arch Dis Child 2007, 92:996-1000.
58. Candy DC, Edwards D, Geraint M: Treatment of faecal impaction with
polyethelene glycol plus electrolytes (PGE + E) followed by a double-
blind comparison of PEG + E versus lactulose as maintenance therapy. J
Pediatr Gastroenterol Nutr 2006, 43:65-70.
59. Gremse DA, Hixon J, Crutchfield A: Comparison of polyethylene glycol
3350 and lactulose for treatment of chronic constipation in children. Clin
Pediatr (Phila) 2002, 41:225-229.
60. Loening-Baucke V, Pashankar DS: A randomized, prospective, comparison
study of polyethylene glycol 3350 without electrolytes and milk of
magnesia for children with constipation and fecal incontinence.
Pediatrics 2006, 118:528-535.
61. Youssef NN, Peters JM, Henderson W, Shultz-Peters S, Lockhart DK, Di LC:
Dose response of PEG 3350 for the treatment of childhood fecal
impaction. J Pediatr 2002, 141:410-414.
62. Michail S, Gendy E, Preud’Homme D, Mezoff A: Polyethylene glycol for
constipation in children younger than eighteen months old. J Pediatr
Gastroenterol Nutr 2004, 39:197-199.
63. Ingebo KB, Heyman MB: Polyethylene glycol-electrolyte solution for
intestinal clearance in children with refractory encopresis. A safe and
effective therapeutic program. Am J Dis Child 1988, 142:340-342.
64. Miller MK, Dowd MD, Fraker M: Emergency department management and
short-term outcome of children with constipation. Pediatr Emerg Care
2007, 23:1-4.
65. Pashankar DS, Bishop WP, Loening-Baucke V: Long-term efficacy of
polyethylene glycol 3350 for the treatment of chronic constipation in
children with and without encopresis. Clin Pediatr (Phila) 2003, 42:815-819.
66. Pashankar DS, Loening-Baucke V, Bishop WP: Safety of polyethylene glycol
3350 for the treatment of chronic constipation in children. Arch Pediatr
Adolesc Med 2003, 157:661-664.
67. Pashankar DS, Bishop WP: Efficacy and optimal dose of daily polyethylene
glycol 3350 for treatment of constipation and encopresis in children. J
Pediatr 2001, 139:428-432.
68. Erickson BA, Austin JC, Cooper CS, Boyt MA: Polyethylene glycol 3350 for
constipation in children with dysfunctional elimination. J Urol 2003,
170:1518-1520.
69. Hanson S, Bansal N: The clinical effectiveness of Movicol in children with
severe constipation: an outcome audit. Paediatr Nurs 2006, 18:24-28.
70. Loening-Baucke V, Krishna R, Pashankar DS: Polyethylene glycol 3350
without electrolytes for the treatment of functional constipation in
infants and toddlers. J Pediatr Gastroenterol Nutr 2004, 39:536-539.
71. Berg I, Forsythe I, Holt P, Watts J: A controlled trial of ‘Senokot’ in faecal
soiling treated by behavioural methods. J Child Psychol Psychiatry 1983,
24:543-549.
72. Sondheimer JM, Gervaise EP: Lubricant versus laxative in the treatment of
chronic functional constipation of children: a comparative study. J
Pediatr Gastroenterol Nutr 1982, 1:223-226.
73. Bellomo-Brandao MA, Collares EF, da-Costa-Pinto EA: Use of erythromycin
for the treatment of severe chronic constipation in children. Brazilian
Journal of Medical & Biological Research 2003, 36(10):1391-1396.
74. Gleghorn EE, Heyman MB, Rudolph CD: No-enema therapy for idiopathic
constipation and encopresis. Clinical Pediatrics 1991, 30(12):669-672.
75. Tolia V, Lin CH, Elitsur Y: A prospective randomized study with mineral oil
and oral lavage solution for treatment of faecal impaction in children.
Aliment Pharmacol Ther 1993, 7:523-529.
76. van GR, Reitsma JB, Buller HA, van Wijk MP, Taminiau JA, Benninga MA:
Childhood constipation: longitudinal follow-up beyond puberty.
Gastroenterology 2003, 125:357-363.
77. Elshimy N, Gallagher B, West D, Stringer MD, Puntis JW: Outcome in
children under 5 years of age with constipation: a prospective follow-up
study. Int J Clin Pract 2000, 54:25-27.
78. Loening-Baucke V: Chronic constipation in children. Gastroenterology 1993,
105:1557-1564.
doi:10.1186/1824-7288-37-28
Cite this article as: Afzal et al.: Constipation in children. Italian Journal of
Pediatrics 2011 37:28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Afzal et al. Italian Journal of Pediatrics 2011, 37:28
http://www.ijponline.net/content/37/1/28
Page 10 of 10